N-methyl-D-aspartate-R1 receptor antisense oligodeoxynucleotide modulates pre- and postsynaptic expression of D2 dopamine receptors in the rat

Neurosci Lett. 2002 Dec 19;335(1):9-12. doi: 10.1016/s0304-3940(02)01161-8.

Abstract

To elucidate the relationship between glutamatergic and dopaminergic transmissions, the effects of antisense oligodeoxynucleotide (aODN) to mRNA of NR1 subunit of N-methyl-D-aspartate (NMDA) receptors on the expression of dopamine D(2) receptors (DRD(2)) were examined. Rats received continuous intracerebroventricular administration (20 nmol /day, for 7 days) of aODN or sense ODN (sODN), or of the same amount of saline. In vitro receptor autoradiography revealed that NR1 aODN induced a significant decrease in specific [(3)H]YM-09151-2 binding in the substantia nigra as compared to sODN and saline. Non-significant decreases were also seen in the ventral tegmental area. Northern blot analysis demonstrated a significant increase in DRD(2) mRNA expression in the striata of aODN-treated animals. These results suggest that specific inhibition of NMDA receptor expression modulates pre- and post-synaptic expression of DRD(2), possibly via reduced nigrostriatal dopaminergic activity.

MeSH terms

  • Animals
  • Autoradiography
  • Benzamides / pharmacology
  • Blotting, Northern
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • Dopamine Antagonists / pharmacology
  • Male
  • Oligonucleotides, Antisense / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Dopamine D2 / drug effects*
  • Receptors, Dopamine D2 / metabolism*
  • Receptors, N-Methyl-D-Aspartate / drug effects
  • Receptors, N-Methyl-D-Aspartate / metabolism*
  • Substantia Nigra / drug effects
  • Substantia Nigra / metabolism*
  • Ventral Tegmental Area / drug effects
  • Ventral Tegmental Area / metabolism*

Substances

  • Benzamides
  • Dopamine Antagonists
  • NR1 NMDA receptor
  • Oligonucleotides, Antisense
  • Receptors, Dopamine D2
  • Receptors, N-Methyl-D-Aspartate
  • nemonapride